ZEFER PHARMA LTD.

Company number 07687584 ·

Active

Net assets, total assets & total liabilities 2016 – 2025

  • Total assets
  • Net assets
  • Total liabilities
-£750k -£500k -£250k £0 £250k £500k £750k 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Total assets 2016: £42,384 Total assets 2017: £217,533 Total assets 2018: £48,150 Total assets 2019: £431,382 Total assets 2020: £715,052 Total assets 2021: £67,289 Total assets 2022: £73,223 Total assets 2023: £78,533 Total assets 2024: £87,131 Total assets 2025: £65,390 Total assets Net assets 2016: £4,804 Net assets 2017: £6,287 Net assets 2018: £8,239 Net assets 2019: £30,847 Net assets 2020: £41,361 Net assets 2021: £47,065 Net assets 2022: £51,245 Net assets 2023: £54,638 Net assets 2024: £58,775 Net assets 2025: £60,118 Net assets Total liabilities 2016: -£37,580 Total liabilities 2017: -£211,246 Total liabilities 2018: -£39,911 Total liabilities 2019: -£400,535 Total liabilities 2020: -£673,691 Total liabilities 2021: -£20,224 Total liabilities 2022: -£21,978 Total liabilities 2023: -£23,895 Total liabilities 2024: -£28,356 Total liabilities 2025: -£5,272 Total liabilities

Figures extracted from filed accounts. Hover a point for the exact value.

Employees 2024 – 2025

0 0 0 0 0 1 2024 2025 2024: 1 2025: 1

Average employees, from filed accounts. Hover a point for the exact figure.

Balance sheet by year 14 years

Latest accounts (2025-06-30): Audit exempt.

Year ending Total assets Total liabilities Net assets Cash Turnover Profit Employees
2025-06-30 £65,390 -£5,272 £60,118 1
2024-06-30 £87,131 -£28,356 £58,775 1
2023-06-30 £78,533 -£23,895 £54,638
2022-06-30 £73,223 -£21,978 £51,245
2021-06-30 £67,289 -£20,224 £47,065
2020-06-30 £715,052 -£673,691 £41,361
2019-06-30 £431,382 -£400,535 £30,847
2018-06-30 £48,150 -£39,911 £8,239
2017-06-30 £217,533 -£211,246 £6,287
2016-06-30 £42,384 -£37,580 £4,804
2015-06-30 £41,964 -£38,589 £3,375 £41,964
2014-06-30 £4,951 -£3,337 £1,614 £4,951
2013-06-30 £2 £2 £2
2012-06-30 £2 £2

Profit and employee figures are captured from accounts filed from August 2026 onwards, where the accounts disclose them.